Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies

被引:5
作者
Barstowe, Aleksandra [1 ]
Kajonius, Petri J. [1 ]
机构
[1] Lund Univ, Dept Psychol, Inst Psykol,Box 213, S-22100 Lund, Sweden
关键词
Masking influences; placebo control; masking; psychedelics; systematic review; LIFE-THREATENING CANCER; PSILOCYBIN TREATMENT; BLINDING ASSESSMENT; CLINICAL-TRIALS; DEPRESSION; ANXIETY; DISORDERS;
D O I
10.1080/02791072.2024.2424272
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Psychedelic-assisted therapy is becoming increasingly acknowledged as an effective therapeutic intervention for various psychiatric illnesses. However, the evaluation of masking success is rarely reported in trials. The objective of the present systematic review was to evaluate placebo-control and masking in studies exploring psychedelic-assisted therapy. Nine (k = 9) studies dating between January 2010 and March 2023 were retrieved using six databases, following strict inclusion and exclusion criteria. The results show that almost 78% of the studies had, at best, "poor" masking success. At the same time, 60% of active placebo and 75% of inactive placebo studies showed large effect sizes. In other words, masking influences, including benign unmasking, cannot be excluded. We therefore conclude that efficacy of psilocybin, Ayahuasca, or LSD is only one of the possible interpretations of large, positive changes in symptomatology for patients suffering from, for example, alcohol use disorder, anxiety with or without life-threatening disease, anxiety and/or depression with life-threatening cancer, treatment-resistant depression or major depressive disorder. We recommend care be taken to increase successful masking procedures and discuss alternative treatment designs to better control for potential masking influences.
引用
收藏
页数:11
相关论文
共 49 条
[1]   Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials [J].
Aday, Jacob S. ;
Heifets, Boris D. ;
Pratscher, Steven D. ;
Bradley, Ellen ;
Rosen, Raymond ;
Woolley, Joshua D. .
PSYCHOPHARMACOLOGY, 2022, 239 (06) :1989-2010
[2]   Systematic Review of Blinding Assessment in Randomized Controlled Trials in Schizophrenia and Affective Disorders 2000-2010 [J].
Baethge, Christopher ;
Assall, Oliver P. ;
Baldessarini, Ross J. .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 (03) :152-160
[3]  
Bang H., 2010, CLIN RES REGUL AFF, V27, P42, DOI DOI 10.3109/10601331003777444
[4]   Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis [J].
Belser, Alexander B. ;
Agin-Liebes, Gabrielle ;
Swift, T. Cody ;
Terrana, Sara ;
Devenot, Nese ;
Friedman, Harris L. ;
Guss, Jeffrey ;
Bossis, Anthony ;
Ross, Stephen .
JOURNAL OF HUMANISTIC PSYCHOLOGY, 2017, 57 (04) :354-388
[5]  
Benedetti F., 2014, PLACEBO EFFECTS, V2nd
[6]   Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial [J].
Bogenschutz, Michael P. ;
Ross, Stephen ;
Bhatt, Snehal ;
Baron, Tara ;
Forcehimes, Alyssa A. ;
Laska, Eugene ;
Mennenga, Sarah E. ;
O'Donnell, Kelley ;
Owens, Lindsey T. ;
Podrebarac, Samantha ;
Rotrosen, John ;
Tonigan, J. Scott ;
Worth, Lindsay .
JAMA PSYCHIATRY, 2022, 79 (10) :953-962
[7]   Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study [J].
Bogenschutz, Michael P. ;
Forcehimes, Alyssa A. ;
Pommy, Jessica A. ;
Wilcox, Claire E. ;
Barbosa, P. C. R. ;
Strassman, Rick J. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) :289-299
[8]   Psilocybin with psychological support for treatment-resistant depression: six-month follow-up [J].
Carhart-Harris, R. L. ;
Bolstridge, M. ;
Day, C. M. J. ;
Rucker, J. ;
Watts, R. ;
Erritzoe, D. E. ;
Kaelen, M. ;
Giribaldi, B. ;
Bloomfield, M. ;
Pilling, S. ;
Rickard, J. A. ;
Forbes, B. ;
Feilding, A. ;
Taylor, D. ;
Curran, H. V. ;
Nutt, D. J. .
PSYCHOPHARMACOLOGY, 2018, 235 (02) :399-408
[9]   Trial of Psilocybin versus Escitalopram for Depression [J].
Carhart-Harris, Robin ;
Giribaldi, Bruna ;
Watts, Rosalind ;
Baker-Jones, Michelle ;
Murphy-Beiner, Ashleigh ;
Murphy, Roberta ;
Martell, Jonny ;
Blemings, Allan ;
Erritzoe, David ;
Nutt, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1402-1411
[10]   Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study [J].
Carhart-Harris, Robin L. ;
Bolstridge, Mark ;
Rucker, James ;
Day, Camilla M. J. ;
Erritzoe, David ;
Kaelen, Mendel ;
Bloomfield, Michael ;
Rickard, James A. ;
Forbes, Ben ;
Feilding, Amanda ;
Taylor, David ;
Pilling, Steve ;
Curran, Valerie H. ;
Nutt, David J. .
LANCET PSYCHIATRY, 2016, 3 (07) :619-627